Burden of vaccine-preventable pneumococcal disease in hospitalized adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network study
Highlights • Active CAP and IPD surveillance was conducted in hospitalized adults since 2010. • Severe outcomes and mortality is seen with CAP and IPD in hospitalized adults. • The serotype distribution suggests most disease in adults is vaccine-preventable. • The incidence of vaccine-preventable pn...
Gespeichert in:
Veröffentlicht in: | Vaccine 2017-06, Vol.35 (29), p.3647-3654 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Highlights • Active CAP and IPD surveillance was conducted in hospitalized adults since 2010. • Severe outcomes and mortality is seen with CAP and IPD in hospitalized adults. • The serotype distribution suggests most disease in adults is vaccine-preventable. • The incidence of vaccine-preventable pneumococcal CAP by age was estimated. • Most vaccine-preventable pneumococcal disease is seen in adults aged ≥50 years. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/j.vaccine.2017.05.049 |